Evaluation status available after sign-in
About the journal
BMC Infectious Diseases is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,790 EUR. Declared review time at DOAJ: 21 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMC
- ISSN
- 1471-2334
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,790 EUR
- Articles in DOAJ
- 13776
- Declared review time
- 21 weeks
- Declared peer-review model
- open_review
- Official website
- https://bmcinfectdis.biomedcentral.com
Index listings
- DOAJ · 2003-04-02
- MEDLINE · 2001-01-01
- PUBMED · 2002-02-06
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 2,790 EUR
- Declared review time (DOAJ)
- 21 weeks
- Actual review time (measured)
- 160 days received→accepted — computed from PubMed (n=96)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
13776
Most recent article
last month
Average review time (journal-declared via DOAJ)
21weeks
Works in OpenAlex
17371
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
176
i10-index
9403
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2003-04-02
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- LOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 13%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- BioMed Central infectious diseasesInfectious diseases
- Source type
- journal
- NLM unique ID (PubMed)
- 100968551
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Infectious and parasitic diseases
LCC codes
RC109-216
Subject areas
- HIV/AIDS Research and Interventions
- Tuberculosis Research and Epidemiology
- Tuberculosis Research and Epidemiology
- Tuberculosis Research and Epidemiology
- Infectious Diseases and Tuberculosis
- HIV/AIDS Research and Interventions
- HIV/AIDS Research and Interventions
- Antibiotic Resistance in Bacteria
Show all subjects (75)
- COVID-19 Clinical Research Studies
- Antibiotic Use and Resistance
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
- Sepsis Diagnosis and Treatment
- SARS-CoV-2 and COVID-19 Research
- Antibiotic Resistance in Bacteria
- COVID-19 Clinical Research Studies
- HIV Research and Treatment
- Antibiotic Resistance in Bacteria
- COVID-19 Clinical Research Studies
- HIV Research and Treatment
- Bacterial Infections and Vaccines
- HIV Research and Treatment
- Antibiotic Use and Resistance
- Diagnosis and treatment of tuberculosis
- Antibiotic Use and Resistance
- Respiratory viral infections research
- Diagnosis and treatment of tuberculosis
- Reproductive tract infections research
- Reproductive tract infections research
- HIV/AIDS drug development and treatment
- Nosocomial Infections in ICU
- Infectious Diseases and Tuberculosis
- Hepatitis C virus research
- HIV/AIDS drug development and treatment
- Bacterial Identification and Susceptibility Testing
- Nosocomial Infections in ICU
- Infectious Diseases and Tuberculosis
- HIV/AIDS drug development and treatment
- Hepatitis C virus research
- HIV-related health complications and treatments
- Hepatitis C virus research
- HIV-related health complications and treatments
- HIV, Drug Use, Sexual Risk
- Hepatitis B Virus Studies
- Parasites and Host Interactions
- Parasites and Host Interactions
- Hepatitis B Virus Studies
- Sepsis Diagnosis and Treatment
- Mosquito-borne diseases and control
- SARS-CoV-2 and COVID-19 Research
- Reproductive tract infections research
- Infection Control in Healthcare
- Mosquito-borne diseases and control
- Sepsis Diagnosis and Treatment
- SARS-CoV-2 and COVID-19 Research
- Bacterial Infections and Vaccines
- Mosquito-borne diseases and control
- Antifungal resistance and susceptibility
- Bacterial Infections and Vaccines
- COVID-19 epidemiological studies
- Hepatitis B Virus Studies
- Malaria Research and Control
- Malaria Research and Control
- Influenza Virus Research Studies
- COVID-19 epidemiological studies
- Fungal Infections and Studies
- Influenza Virus Research Studies
- COVID-19 epidemiological studies
- Influenza Virus Research Studies
- Diagnosis and treatment of tuberculosis
- Antifungal resistance and susceptibility
- Antifungal resistance and susceptibility
Keywords (DOAJ)
- infectious diseases
- sexually transmitted diseases
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ